Haut.AI, a SaaS company specializing in artificial intelligence for skin, hair, and wellness analytics, has just announced its new generative AI tech for modeling skin conditions - SkinGPT. This breakthrough in the beauty industry uses AI to create synthetic images and apply skin conditions to input image data. SkinGPT enables users to upload their photos and apply AI to simulate how their skin will change over time when using certain skincare products.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology today announced the availability of Philips HealthSuite Imaging on Amazon Web Services (AWS). Additionally, Philips and AWS will build on their relationship, advancing AI in healthcare by applying Foundation Models using Amazon Bedrock to accelerate the development of cloud-based generative AI applications that will provide clinical decision support, help enable more accurate diagnoses, and automate administrative tasks.

David Hancock, a long-standing expert on the health tech industry with a passion for interoperability, has become an associate of Highland Marketing.

In his new role, David will support clients of the specialist digital health agency that need advice on market entry or positioning, so they can communicate effectively with IT leaders at every level.

Opinion Article by Dr Mark Ratnarajah, NHS Paediatrician, UK Managing Director, C2-Ai.
Clinical teams continue to work relentlessly to get through the elective backlog. I see it every day with frontline colleagues, and with clinical leads I speak to at organisational and regional levels. Their aim is to help as many patients as possible in the face of a highly complex and enduring peri-pandemic challenge.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced the debut of Philips Virtual Care Management, a comprehensive portfolio of flexible solutions and services to help health systems, providers, payers and employer groups more meaningfully motivate and deeply connect with patients from virtually anywhere.

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-powered drug discovery company, has integrated advanced AI chat functionality based on recent advances in large language models into its PandaOmics platform. The new feature, "ChatPandaGPT," enables researchers to have natural language conversations with the platform and efficiently navigate and analyze large datasets, facilitating the discovery of potential therapeutic targets and biomarkers in a more efficient manner.

BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned, independently operated subsidiary of Bayer AG, announced a collaboration with Rune Labs and Emerald Innovations focused on using wearable and invisible contactless digital health technology to improve monitoring and data collection for Parkinson's disease clinical trials.